Adjust text size: A | A | A

Lung Cancer Research Programs

2009

  • The immune system detects invaders, and serum antibodies have been used to diagnose viral and bacterial infections for decades. Useful tumor-specific antigens were harder to find, but modern...

    | More…
  • About 170 000 patients are yearly diagnosed with NSCLC, most of these with advanced stages. The 5 year survival is about 14%. About 10% of lung cancers arise in never-smokers. About half of these...

    | More…
  • Lung cancer is the most common cause of cancer death among both men and women in the U.S. The primary reason for shortened patient survival is the onset of metastasis, or widespread disease...

    | More…
  • Lung cancer is the leading cause of cancer deaths in the United States, and approximately 20% of cases occur in never smokers. Recently, it has become clear that never smokers with non-small cell...

    | More…
  • SCLC has been treated with the same chemotherapy drugs, etoposide and cisplatin, for the past 30 years. While this chemotherapy treatment often works well initially and can result in remissions,...

    | More…
  • As the leading cause of cancer deaths in western industrial countries, lung cancer can be grouped into small cell lung cancer and non-small cell lung cancer. Surgery is the most effective...

    | More…
  • Lung cancer is the number one cancer killer claiming more than 160,000 lives annually in the United States. Small cell lung cancer which accounts for about 20% of all lung cancers, (SCLC) is one...

    | More…
  • Small cell lung cancer is a deadly disease with no curative treatment. The goal of this project is to discover genetic changes that drive the formation of small cell lung cancer. We then intend...
    | More…
  • Lung cancer is the leading cause of cancer-related deaths worldwide. Lung cancer cells have been shown to carry frequent structural chromosomal abnormalities such as deletions of specific regions...

    | More…
  • The cells that constitute normal tissues carry out elaborate mechanisms to ensure proper function and growth. These mechanisms include checkpoints that prevent uncontrolled cell division....

    | More…

Spread the word

Share |

Sign up for Updates from Uniting

Uniting Against Lung Cancer: 27 Union Square West, Suite 304, New York, NY 10003 • Tel: 212.627.5500 • Fax: 212.627.7594. Privacy Policy
Uniting Against Lung Cancer is a tax exempt 501(c)(3) nonprofit corporation with the EIN 13 419 5464.

Site design & development by Raised Eyebrow Web Studio, Inc.